Campral FDA Approval History
FDA Approved: Yes (Discontinued) (First approved July 29, 2004)
Brand name: Campral
Generic name: acamprosate calcium
Dosage form: Delayed-Release Tablets
Company: Allergan plc
Treatment for: Alcohol Use Disorder
Marketing Status: Discontinued
Campral (acamprosate calcium) is a synthetic compound resembling the endogenous amino acid homotaurine indicated for treating alcohol dependence.
Development timeline for Campral
| Date | Article |
|---|---|
| Jul 29, 2004 | Approval Campral Forest Laboratories, Inc. and Merck - Treatment for Alcoholism |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
